Immunotherapeutic strategies in patients with advanced head and neck squamous cell carcinoma
Ann Transl Med
.
2019 Mar;7(Suppl 1):S22.
doi: 10.21037/atm.2019.01.72.
Authors
Maysaloun Merhi
1
2
,
Afsheen Raza
1
2
,
Varghese Inchakalody
1
2
,
Abdul Rahman Zar
1
,
Shahab Uddin
3
,
Said Dermime
1
2
Affiliations
1
National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
2
Translational Cancer Research Facility, Hamad Medical Corporation, Doha, Qatar.
3
Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
PMID:
31032302
PMCID:
PMC6462621
DOI:
10.21037/atm.2019.01.72
No abstract available
Publication types
Editorial
Comment